A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer

Published:2020-07-09 Issue:8 Volume:17 Page:3140-3147
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Fung Kimberly¹²,Sharma Sai Kiran,Keinänen Outi¹^ORCID,Roche Kara Long³,Lewis Jason S.^ORCID,Zeglis Brian M.¹²^ORCID

Affiliation:

1. Department of Chemistry, Hunter College, City University of New York, New York, New York 10021, United States

2. Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, New York 10016, United States

3. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00437

Reference35 articles.

1. Cancer statistics, 2020

2. The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer

3. Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

4. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

5. Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Fluorescent Furan‐based Probe with Protected Functional Groups for Highly Selective and Non‐Toxic Imaging of HT‐29 Cancer Cells and 4T1 Tumors;ChemPlusChem;2024-07-12

2. Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6;Molecular Cancer Therapeutics;2024-02-23

3. Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery;Medicinal Research Reviews;2024-02-17

4. Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future;Cancers;2023-10-03

5. The Application of Nanoparticle‐Based Imaging and Phototherapy for Female Reproductive Organs Diseases;Small;2023-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3